Literature DB >> 18035493

TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I.

Ilya Sabsovich1, Tian-Zhi Guo, Tzuping Wei, Rong Zhao, Xiangqi Li, David J Clark, Christian Geis, Claudia Sommer, Wade S Kingery.   

Abstract

Tibia fracture in rats initiates a cascade of nociceptive, vascular, and bone changes resembling complex regional pain syndrome type I (CRPS I). Previous studies suggest that the pathogenesis of these changes is attributable to an exaggerated regional inflammatory response to injury. We postulated that the pro-inflammatory cytokine tumor necrosis factor alpha (TNF) might mediate the development of CRPS-like changes after fracture. RT-PCR and EIA assays were used to evaluate changes in TNF expression and content in skin, nerve, and bone after fracture. Bilateral hindpaw thickness, temperature, and nociceptive thresholds were determined, and bone microarchitecture was measured using microcomputed tomography. Lumbar spinal cord Fos immunostaining was performed for quantification of Fos positive neurons. After baseline testing, the distal tibia was fractured and the hindlimb casted for 4 weeks. The rats were subcutaneously injected either with a soluble TNF receptor type 1 (sTNF-R1, 5mg/kg/d) or saline every 3 days over 28 days and then were retested at 4 weeks post-fracture. Tibia fracture chronically upregulated TNF expression and protein levels in the hindpaw skin and sciatic nerve. After fracture the rats developed hindpaw mechanical allodynia and unweighting, which were reversed by sTNF-R1 treatment. Consistent with the behavioral data, spinal Fos increased after fracture and this effect was inhibited by sTNF-R1 treatment. Collectively, these data suggest that facilitated TNF signaling in the hindlimb is an important mediator of chronic regional nociceptive sensitization after fracture, but does not contribute to the hindlimb warmth, edema, and bone loss observed in this CRPS I model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035493      PMCID: PMC2529181          DOI: 10.1016/j.pain.2007.10.013

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  41 in total

1.  Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.

Authors:  Felipe F Rodrigues; Marcela I Morais; Ivo S F Melo; Paulo S A Augusto; Marcela M G B Dutra; Sarah O A M Costa; Fábio C Costa; Franciele A Goulart; Alysson V Braga; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2019-11-25       Impact factor: 4.473

2.  Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.

Authors:  Liping Wang; Tian-Zhi Guo; Saiyun Hou; Tzuping Wei; Wen-Wu Li; Xiaoyou Shi; J David Clark; Wade S Kingery
Journal:  Anesth Analg       Date:  2016-10       Impact factor: 5.108

3.  Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.

Authors:  Tian-Zhi Guo; Tzuping Wei; Wen-Wu Li; Xiang-Qi Li; J David Clark; Wade S Kingery
Journal:  J Pain       Date:  2014-07-22       Impact factor: 5.820

Review 4.  Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back.

Authors:  Elena S Haight; Thomas E Forman; Stephanie A Cordonnier; Michelle L James; Vivianne L Tawfik
Journal:  Anesth Analg       Date:  2019-04       Impact factor: 5.108

5.  Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; De-yong Liang; Yuan Sun; Wade S Kingery; J David Clark
Journal:  Anesthesiology       Date:  2012-04       Impact factor: 7.892

6.  Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.

Authors:  W-W Li; T-Z Guo; X Shi; Y Sun; T Wei; D J Clark; W S Kingery
Journal:  Neuroscience       Date:  2015-09-16       Impact factor: 3.590

Review 7.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

8.  Activation of cutaneous immune responses in complex regional pain syndrome.

Authors:  Frank Birklein; Peter D Drummond; Wenwu Li; Tanja Schlereth; Nahid Albrecht; Philip M Finch; Linda F Dawson; J David Clark; Wade S Kingery
Journal:  J Pain       Date:  2014-01-23       Impact factor: 5.820

Review 9.  New Concepts in Complex Regional Pain Syndrome.

Authors:  Maral Tajerian; John David Clark
Journal:  Hand Clin       Date:  2016-02       Impact factor: 1.907

10.  Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.

Authors:  Wenwu Li; Xiaoyou Shi; Liping Wang; Tianzhi Guo; Tzuping Wei; Kejun Cheng; Kenner C Rice; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2013-04-12       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.